An optimized peptide vaccine strategy capable of inducing multivalent CD8(+) T cell responses with potent antitumor effects.
about
Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell VaccinationTo Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic VirusesIs There Still Room for Cancer Vaccines at the Era of Checkpoint InhibitorsTrial Watch: Immunotherapy plus radiation therapy for oncological indications.Co-expression of CD40L with CD70 or OX40L increases B-cell viability and antitumor efficacy.A novel Epstein-Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy.
P2860
An optimized peptide vaccine strategy capable of inducing multivalent CD8(+) T cell responses with potent antitumor effects.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
An optimized peptide vaccine s ...... with potent antitumor effects.
@en
type
label
An optimized peptide vaccine s ...... with potent antitumor effects.
@en
prefLabel
An optimized peptide vaccine s ...... with potent antitumor effects.
@en
P2093
P2860
P1433
P1476
An optimized peptide vaccine s ...... with potent antitumor effects.
@en
P2093
Esteban Celis
Hyun-Il Cho
Hyun-Jung Sohn
Soo-Hyun Jung
Tai-Gyu Kim
P2860
P304
P356
10.1080/2162402X.2015.1043504
P577
2015-05-26T00:00:00Z